Get the Stockscreener App
10.50
4.11%
-0.45
Dynavax Technologies Corp stock is traded at $10.50, with a volume of 3.70M.
It is down -4.11% in the last 24 hours and down -6.08% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$10.95
Open:
$10.93
24h Volume:
3.70M
Relative Volume:
2.36
Market Cap:
$1.23B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
80.77
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-2.69%
1M Performance:
-6.08%
6M Performance:
-21.23%
1Y Performance:
-6.91%
1-Day Range:
$10.48
$10.97
1-Week Range:
$10.28
$11.45
52-Week Range:
$9.22
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
10.50 | 1.26B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
What earnings revisions data tells us about Dynavax Technologies CorporationWeekly Stock Analysis & Safe Capital Investment Plans - Newser
Has Dynavax Technologies Corporation formed a bullish divergenceJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Dynavax Technologies Corporation stock trend outlook and recovery pathWeekly Trend Report & Safe Swing Trade Setups - Newser
When is the best time to exit Dynavax Technologies CorporationMarket Performance Report & Fast Gain Swing Trade Alerts - Newser
Statistical indicators supporting Dynavax Technologies Corporation’s strengthJuly 2025 Market Mood & Low Risk High Reward Trade Ideas - Newser
Will Dynavax Technologies Corporation benefit from macro trendsQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Analyzing drawdowns of Dynavax Technologies Corporation with statistical toolsTrade Exit Summary & Weekly Breakout Stock Alerts - Newser
Detecting support and resistance levels for Dynavax Technologies CorporationMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
What data driven models say about Dynavax Technologies Corporation’s future2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
Measuring Dynavax Technologies Corporation’s beta against major indices2025 Market Sentiment & Daily Price Action Insights - Newser
Is Dynavax Technologies Corporation stock entering bullish territoryJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - Newser
How to recover losses in Dynavax Technologies Corporation stockShare Buyback & Step-by-Step Trade Execution Guides - Newser
Analyzing net buyer seller activity in Dynavax Technologies CorporationQuarterly Profit Review & Community Verified Swing Trade Signals - Newser
Historical volatility pattern of Dynavax Technologies Corporation visualized2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
Dynavax Technologies Corporation stock prediction for this weekProfit Target & Daily Technical Forecast Reports - Newser
Using Python tools to backtest Dynavax Technologies Corporation strategies2025 Big Picture & Community Trade Idea Sharing Platform - Newser
Published on: 2025-08-15 11:14:16 - 선데이타임즈
Dynavax’s SWOT analysis: heplisav-b success drives stock outlook amid pipeline progress - Investing.com
Natixis Advisors LLC Has $341,000 Stake in Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
Real time social sentiment graph for Dynavax Technologies Corporation [Market Sentiment Summary]Verified Swing Trading Watchlists - Newser
Analyzing Dynavax Technologies Corporation with multi timeframe chartsSafe Investment Ideas with Growth Upside - Newser
What makes Dynavax Technologies Corporation stock price move sharplyM&A Rumor & Safe Entry Point Identification - Newser
Is Dynavax Technologies Corporation forming a bottoming baseTrade Flow Monitor with Volume Tracker - Newser
Q3 EPS Forecast for Dynavax Technologies Reduced by Analyst - Defense World
Why Dynavax Technologies Corporation stock attracts strong analyst attention2-Day Signal Watch with Forecast Outcome - Newser
How moving averages guide Dynavax Technologies Corporation tradingFree Entry Points For Growing Stocks - Newser
Reversal indicators forming on Dynavax Technologies Corporation stockTechnical Screener for High Growth Stocks - Newser
Published on: 2025-08-10 01:43:26 - Newser
What moving averages say about Dynavax Technologies CorporationFree Beginner Friendly Stock Selection Guide - Newser
Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2025 Earnings Call Transcript - Insider Monkey
Pattern recognition hints at Dynavax Technologies Corporation upsideCommunity Picked Stocks with Trade Insights - Newser
Dynavax Technologies (NASDAQ:DVAX) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Dynavax Technologies Corporation stock chart pattern explainedAI Model Forecasting Reversal and Breakout Zones - Newser
Dynavax Technologies (NASDAQ:DVAX) Upgraded to “Buy” at Wall Street Zen - Defense World
Dynavax Technologies Corp (DVAX) Q2 Revenue Up 30.9% YoY, Despite High Operating Expenses and Net Loss of $77.378 Million. - AInvest
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25 - 富途牛牛
Dynavax Technologies: JMP Securities Maintains Market Outperform, PT Raised to $32. - AInvest
Real time social sentiment graph for Dynavax Technologies CorporationPredictive Screener for Daily Trade Watch - Newser
Earnings call transcript: Dynavax beats Q2 2025 forecasts, stock dips - Investing.com
Earnings call transcript: Dynavax beats Q2 2025 forecasts, stock dips By Investing.com - Investing.com UK
Dynavax Q2 2025 slides: HEPLISAV-B sales surge 31% YoY, pipeline advances - Investing.com
Dynavax Technologies Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):